Opioid Prescribing Patterns of Optometrists in the Medicare Part D Database

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Stephen C. Dryden ◽  
Holly A. O’Malley ◽  
Lindsey R. Adams ◽  
Garrett C. Nix ◽  
Jonathan E. Rho ◽  
...  
2017 ◽  
Vol 76 (3) ◽  
pp. 337-353 ◽  
Author(s):  
Elissa Ladd ◽  
Casey Fryer Sweeney ◽  
Anthony Guarino ◽  
Alex Hoyt

Many state legislatures restrict nurse practitioner (NP) scope of practice as a way of addressing patient safety concerns. The purpose of this study was to investigate the influence of state NP scope of practice laws on the prescription of oxycodone and hydrocodone containing medications by NP and MD/DO/PA prescribers to Medicare Part D beneficiaries. Using the Medicare Part D public use file, we analyzed oxycodone and hydrocodone containing prescriptions per Medicare Part D beneficiary by prescriber type, NP state scope of practice, and geographic variables. Our results demonstrate that the state scope of practice variable had the same effect, in identical direction and significance, on NP opioid prescribing patterns as it had on MD/DO/PA prescribers, a group to whom NP scope of practice laws do not apply. Thus, scope of practice in this study was not an exclusive predictor of NP practice and prescribing.


JAMA Oncology ◽  
2020 ◽  
Vol 6 (8) ◽  
pp. 1271
Author(s):  
Ankit Agarwal ◽  
Andrew Roberts ◽  
Stacie B. Dusetzina ◽  
Trevor J. Royce

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. 2070-2070
Author(s):  
Trevor Joseph Royce ◽  
Andrew Roberts ◽  
Stacie Dusetzina ◽  
Ankit Agarwal

2070 Background: In response to the opioid crisis, recent policies aiming to reduce opioid prescribing, misuse, & abuse have generated concern that patients with cancer pain may unintentionally experience reduced access to necessary opioid therapy. It is unknown how opioid prescribing patterns have changed between generalists and oncologists during this era. Methods: We conducted a longitudinal repeated cross-sectional study estimating adjusted annual national trends in opioid prescribing among generalists & oncologists using the Medicare Part D Prescriber Public Use Files 2013-2017. Poisson models estimated annual adjusted predicted mean rates of opioid prescribing-per-1,000 total prescriptions & long-acting opioid prescribing per-1,000 opioid prescriptions. Poisson models estimated adjusted incidence rate ratios (aIRRs) to quantify annual changes in prescribing rates. Results: From 2013-2017 the annual adjusted predicted mean rate of opioid prescriptions per 1,000 total prescriptions decreased from 53.4 to 41.3 among generalists (aIRR = 0.78; p < 0.01) and from 133.2 to 105.9 among oncologists (aIRR = 0.83; p < 0.01). The rate of long-acting opioid fills per 1,000 opioid prescriptions decreased from 96.0 to 87.0 (aIRR = 0.87; p < 0.01) and 235.1 to 222.5 (aIRR = 0.95; p < 0.01) for generalists & oncologists, respectively (Table). Conclusions: We found large declines in overall opioid prescribing rates among generalists (-22%) and oncologists (-17%) from 2013-2017. Long-acting opioid prescribing rates decreased over 2.5-times more among generalists than oncologists. Opioid policy & advocacy have been effective in reducing the extent of opioid prescribing in the Medicare population but how much of the decrease in prescribing by oncologists is ‘appropriate’ versus ‘inappropriate’ deserves further investigation. [Table: see text]


Author(s):  
Stephen C. Dryden ◽  
Garrett C. Nix ◽  
Jonathan E. Rho ◽  
Albert B. Vacheron ◽  
Samuel C. Fowler ◽  
...  

Orbit ◽  
2021 ◽  
pp. 1-6
Author(s):  
Stephen C. Dryden ◽  
Jonathan E. Rho ◽  
Garrett C. Nix ◽  
Albert B. Vacheron ◽  
Sara N. Reggie ◽  
...  

Pain Medicine ◽  
2020 ◽  
Vol 21 (7) ◽  
pp. 1400-1407 ◽  
Author(s):  
Adam N Romman ◽  
Connie M Hsu ◽  
Lin-Na Chou ◽  
Yong-Fang Kuo ◽  
Rene Przkora ◽  
...  

Abstract Objective To examine opioid prescribing frequency and trends to Medicare Part D enrollees from 2013 to 2017 by medical specialty and provider type. Methods We conducted a retrospective, cross-sectional, specialty- and provider-level analysis of Medicare Part D prescriber data for opioid claims from 2013 to 2017. We analyzed opioid claims and prescribing trends for specialties accounting for ≥1% of all opioid claims. Results From 2013 to 2017, pain management providers increased Medicare Part D opioid claims by 27.3% to 1,140 mean claims per provider in 2017; physical medicine and rehabilitation providers increased opioid claims 16.9% to 511 mean claims per provider in 2017. Every other medical specialty decreased opioid claims over this period, with emergency medicine (–19.9%) and orthopedic surgery (–16.0%) dropping opioid claims more than any specialty. Physicians overall decreased opioid claims per provider by –5.2%. Meanwhile, opioid claims among both dentists (+5.6%) and nonphysician providers (+10.2%) increased during this period. Conclusions From 2013 to 2017, pain management and PMR increased opioid claims to Medicare Part D enrollees, whereas physicians in every other specialty decreased opioid prescribing. Dentists and nonphysician providers also increased opioid prescribing. Overall, opioid claims to Medicare Part D enrollees decreased and continue to drop at faster rates.


2017 ◽  
Vol 33 (2) ◽  
pp. 60-65 ◽  
Author(s):  
Mukaila A. Raji ◽  
Yong-Fang Kuo ◽  
Nai-Wei Chen ◽  
Hunaid Hasan ◽  
Denise M. Wilkes ◽  
...  

Background: Pain management clinics are major sources of prescription opioids. Texas government passed several laws regulating pain clinics between 2009 and 2011 to reduce opioid-related toxicity. Understanding the impact of these laws can inform policy geared toward making the laws more effective in curbing the growing epidemic of opioid overdose, especially among the elderly population. Objectives: To examine the longitudinal association of laws regulating pain clinics on opioid-prescribing and opioid-related toxicity among Texas Medicare recipients. Methods: The 2007 to 2012 claims data for Texas Medicare Part D recipients were used to assess temporal trends in the percentage of patients filling any schedule II or schedule III opioid prescription, hospitalization for opioid toxicity, and their relationships to the 2009 to 2011 Texas laws regulating pain clinics. We excluded those with a cancer diagnosis. Join-point trend analysis with Bayesian Information Criterion selection methods were used to evaluate the change in monthly percentages of patients filling opioid prescriptions and hospitalization over time. Results: There was a short-lived decline in the monthly percentages of patients who filled a schedule II or schedule III opioid prescription after the 2009 laws regulating pain clinics. The decline lasted about 3 months. Subsequent new laws had no effect on the percentages of patients who filled any opioid prescription or were hospitalized for potential opioid toxicity. Hospitalizations for opioid toxicity were highest in the winter and lowest in the summer. Conclusions: Changes in the percentages of opioid-prescribing or opioid-related hospitalizations over time were not associated with laws regulating pain clinics.


2018 ◽  
Vol 112 ◽  
pp. e31-e38 ◽  
Author(s):  
Syed I. Khalid ◽  
Owoicho Adogwa ◽  
Daniel T. Lilly ◽  
Shyam A. Desai ◽  
Victoria D. Vuong ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document